Literature DB >> 12845351

What is the Helicobacter pylori global reinfection rate?

Julie Parsonnet1.   

Abstract

Reinfection with any organism is related to the force of infection in the population and on both innate and acquired immunity to infection. Little is yet known about primary immune protection against Helicobacter pylori. Some data suggest that children can be recurrently infected, spontaneously eliminating the organism only to be infected again and again until the organism takes hold. This pattern of recurrent infection is not observed in patients who receive eradication therapy for chronic infection. After eradication of infection, the rate of reinfection is probably slightly lower than the primary infection rate in that age group, suggesting some level of acquired immunity. In developed countries, reinfection of adults in unusual, and recurrence usually represents failure of primary eradication rather than new infection. Some cases of reinfection do occur, however. Given that acquired immunity probably varies little from population to population, reinfections will most likely occur in areas where the force of infection is high, ie, where both the prevalence of infection and the opportunities for transmission are high.

Entities:  

Mesh:

Year:  2003        PMID: 12845351     DOI: 10.1155/2003/567816

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  14 in total

1.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model.

Authors:  F Alarid-Escudero; E A Enns; R F MacLehose; J Parsonnet; J Torres; K M Kuntz
Journal:  Epidemiol Infect       Date:  2018-04-16       Impact factor: 2.451

Review 3.  Vaccinating against Helicobacter pylori in the developing world.

Authors:  Shamila Zawahir; Steven J Czinn; John G Nedrud; Thomas G Blanchard
Journal:  Gut Microbes       Date:  2013-11-06

Review 4.  Optimal therapy for Helicobacter pylori infections.

Authors:  Emiko Rimbara; Lori A Fischbach; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

5.  The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma.

Authors:  Anne Mueller; Jani O'rourke; Pauline Chu; Amanda Chu; Michael F Dixon; Donna M Bouley; Adrian Lee; Stanley Falkow
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.

Authors:  Jennifer M Yeh; Karen M Kuntz; Majid Ezzati; Sue J Goldie
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

Review 7.  Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations.

Authors:  K J Goodman; K Jacobson; S Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

8.  Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.

Authors:  Jennifer M Yeh; Sue J Goldie; Karen M Kuntz; Majid Ezzati
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

9.  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

Authors:  Douglas R Morgan; Javier Torres; Rachael Sexton; Rolando Herrero; Eduardo Salazar-Martínez; E Robert Greenberg; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Eduardo C Lazcano-Ponce; Maria Mercedes Meza-Montenegro; Edgar M Peña; Rodolfo Peña; Pelayo Correa; María Elena Martínez; William D Chey; Manuel Valdivieso; Garnet L Anderson; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

10.  Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples.

Authors:  Mitsushige Sugimoto; Jeng-Yih Wu; Suhaib Abudayyeh; Jill Hoffman; Hajer Brahem; Khaldun Al-Khatib; Yoshio Yamaoka; David Y Graham
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.